ArticleCancer immunology, immunotherapy : CII1989

Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

K Ryoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.